In a recent move, the Indian government implemented zero GST on 36 life-saving drugs, including crucial medications for cancer. This decision aims to alleviate financial burdens on patients and their families. Ameera Shah, President of NATHEALTH, emphasizes that this change will make healthcare more affordable. It promotes early disease detection and ensures consistency in GST rates for various healthcare services.
Dr. Dilip Bhanushali, National President of the Indian Medical Association, praised the government’s action, noting that they previously requested broader GST exemptions for essential drugs. This includes anti-diabetic and cardiac medications. His support underscores the importance of affordable healthcare in India.
Experts in the healthcare industry, like Dr. Aashish Chaudhry from Aakash Healthcare, expect these changes to lead to lower costs for patients. He believes that reduced out-of-pocket expenses will encourage consistent treatment adherence and ultimately improve health outcomes nationwide.
Dr. Aakaar Kapoor, CEO of City Imaging and Clinical Labs, noted that lowering GST on medical equipment and diagnostic tools is a significant relief for healthcare providers. He also called for a complete waiver of GST on all healthcare services to ensure sustainable, high-quality care for everyone.
Dr. Harsh Mahajan, Chairman of FICCI’s Health Services, hopes the government will consider further reducing GST on maintenance service contracts for medical equipment. Lower costs could enhance the healthcare sector’s capability to serve the public effectively.
This shift in policy highlights a growing focus on making healthcare more accessible in India. Recent data shows that nearly 70% of Indians struggle to afford necessary medical treatments. By addressing these financial challenges, the government is taking steps towards a healthier population.
For more insights on healthcare policies and their impacts, you can check out NATHEALTH’s official website.
Source link
GST,JP Nadda
